MedStar Health
Washington D.C., District of Columbia, 20007, United States
Location status: Recruiting
Location contact
Andrew Canning
CONTACT
NCT Number: NCT04675476
To test the impact of a multilevel intervention on primary (provider-patient communication, intentions, and knowledge) and secondary (screening referrals and completion) outcomes.
Interested in participating?
Request Info50 year–80 year
All sexes
Interventional
Not applicable
Washington D.C., District of Columbia, 20007, United States
Location status: Recruiting
Andrew Canning
CONTACT
The proposed study will target two key levels of influence in the healthcare setting: provider and patient behavior in order to address disparities between African American and whites in lung screening awareness and utilization. Guided by NIH's Health Disparities Research Framework and building on the formative work conducted in the K99 phase, we will conduct a quasi-experimental study (pretest-posttest, with a nonequivalent control group) in partnership with four primary care clinics within the MedStar Health system in the R00 phase.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
To target lack of provider-prompted discussion about lung screening, an electronic medical record (EMR) message will be sent to primary care providers prior to scheduled visits with screening-eligible patients to notify them of the patient's eligibility and to encourage discussion of the benefits and limitations of the test. To target patient-level knowledge about lung screening, an outreach specialist will educate screening-eligible patients about the benefits and limitations of the test prior to their visit.
Time frame: 1-week post-visit
Discussion about lung screening with the provider ('did you have a discussion with your doctor about lung screening?')
Time frame: 1-week post-visit
Screening intentions ('how likely is it that you will undergo lung screening in the next 6-months?')
Time frame: 1-week post-visit
Lung cancer screening knowledge measure
Time frame: 6-months
Total number of lung screening orders captured via the electronic medical record
Time frame: 6-months
Total number of lung screening completions captured via the electronic medical record
Contact information is provided by the study sponsor or research team.
Georgetown University
Other
A Multilevel Intervention to Address Health Disparities in Lung Cancer Screening
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07646847
Bladder Cancer, Breast Cancer
Basking Ridge, New Jersey, United States
View Trial DetailsNCT07740239
Brain Diseases, Brain Metastasis
Tampere, Finland
View Trial DetailsNCT06540196
Bronchial Neoplasms, Carcinoma, Bronchogenic
Hamilton, Ontario, Canada
View Trial DetailsNCT06410300
Lung Cancer, Lung Diseases
Columbia, Missouri, United States
View Trial Details